Inaccurate Glycosylated Hemoglobin A1C Measurements in Human Immunodeficiency Virus—Positive Patients with Diabetes Mellitus | Zendy

Philip M. Polgreen | Zendy; Darcy Putz | Zendy; Jack T. Stapleton | Zendy

Open Access

Inaccurate Glycosylated Hemoglobin A1C Measurements in Human Immunodeficiency Virus—Positive Patients with Diabetes Mellitus

Author(s) -

Philip M. Polgreen,

Darcy Putz,

Jack T. Stapleton

Publication year - 2003

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/376633

Subject(s) - medicine , diabetes mellitus , hemoglobin , human immunodeficiency virus (hiv) , virology , immunopathology , type 2 diabetes mellitus , immunology , endocrinology

Persistent differences in blood glucose and serum glycosylated hemoglobin (HbA1C) measurements were observed in 4 human immunodeficiency virus-positive patients with diabetes mellitus, all of whom were taking drugs associated with hemolysis, which interferes with the reliability of HbA1C levels. Determination of fructosamine levels was a more accurate alternative for measuring average glycemic control in these patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research